News Conference News ACC 2017 ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More Shelley Wood March 10, 2017
Presentation JIM 2017 Complete Cerebral Embolic Protection Utilizing TriGuard™ Presenter: Azeem Latib February 10, 2017